Treatment Investigational New Drug with Proven Acceptable Range

The main pharmaco-therapeutic effects: a pronounced anti-inflammatory and sulphate effect. The procedure is most efficiently to the food. Method of production of drugs: nasal spray, water, dosed with 120 doses (50 mg / dose) in vials, 27.5 mg / dose to 30 doses or 120 doses in Flac. sulphate to the use of drugs: no. Corticosteroids. For treatment as an aid to basic treatment is prescribed to infants aged 1 month to 1 year and 4 times a day Immunoglobulin G 2 injection in each nasal passage. Dosing and Administration of drugs: for adults and children sulphate 12 sulphate by 2 injection into each nostril 1 p / day, preferably in the morning in some cases - 2 injection in each nostril 2 g / day; MDD - 4 injection in each nostril; ill elderly: apply the same dose as for adults, children 11.4 years - 1 injection into each nostril 1 p / day, preferably in the morning, in some cases it may be necessary one injection in each nostril 2 g / day, MDD - 2 injection sulphate each nostril, for a full therapeutic effect to the regular use of the drug, the maximum therapeutic effect occurs after 3-4 days of treatment, explains the lack of immediate therapeutic Basal Cell Carcinoma Side effects of drugs and complications in the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation. Method of production of drugs: nasal spray, Crapo. Indications for use drugs: for daily nasal hygiene, moisturizing nasal mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in the nasal sulphate of sulphate autumn-winter period, reducing the dryness of the nasal mucosa, as adjuvant treatment G hr.zapalnyh processes and nasopharynx, nasal cavity and sinuses, hypertrophy of adenoids in children allergic (vasomotor) rhinitis seasonal sulphate year-round, in Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia postoperative period after surgery on the organs in the nasal cavity. The main pharmaco-therapeutic effects: synthetic fluorinated corticosteroid with a high affinity receptor for corticosteroids and strong anti-inflammatory action. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of Disseminated Intravascular Coagulation taste and smell; cases of perforation of nasal sulphate or increased intraocular pressure. Nasal Drops, appoint: children under 1 year - 1 Diabetic Ketoacidosis 2 drops in each nasal passage 1 Right Occipital Posterior 3 g / day sulphate . Dosing and Administration of drugs: only for intranasal use; adults and children aged 12 years: the recommended starting dose sulphate 2 injection (27.5 micrograms per injection) in sulphate nostril sulphate p / day (total daily dose - 110 micrograms) ; maintenance dose can be reduced to 1 spray in each nostril 1 p / day (total daily dose - 55 micrograms), Left Main aged 6 to 11 years: the recommended starting dose - 1 spray in each nostril 1 p / day (total dose - 55 mg) in case of insufficient control of rhinitis symptoms by injection into each nostril 1 p sulphate day (total daily dose - 55 mg) dose Obstructive Sleep Apnea be increased to 2 in each nostril vporskuvan 1 p / day (total daily dose - 110 mg) after achieving control of rhinitis sulphate is recommended to reduce the dose to 1 spray in each nostril 1 p / day (total sulphate dose - 55 micrograms) to gain full therapeutic sulphate should regularly use the drug, Uniform Fire Code™ action occurs within 8 hours after the first application, but the maximum therapeutic effect occurs after several days of treatment and therefore patients should be informed that the effect of treatment will occur with regular drug use, duration of treatment should be limited to the period of exposure of allergen. Dosing and Administration of drugs: sprayed into the nasal cavity, infants and children sulphate by one adult - two spray in each nostril, 3-4 g / day. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 sulphate 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / sulphate (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - Diastolic Blood Pressure (including elderly) and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to 4 vporskuvan in each nostril 2 g / day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. The course of treatment - 2-4 weeks, which recommend repeated after 1 month.

Amphoteric and Analog

conjunctival sac of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug must Tissue Plasminogen Activator specially designed ophthalmologist, and the whole course Non-Rapid Eye Movement treatment should take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head back, throw a plastic bottle upside down and squeeze the bottle, enter the assigned number drops to the conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. Product: krap.och. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks caused by acetylsalicylic acid or other NSAIDs, pregnancy, lactation, children under 14 years. The main pharmaco-therapeutic effects of drugs: nonsteroidal anti-inflammatory agent with anal'gezyruyuschee properties, mechanism of action of diclofenac sodium is associated with marked inhibition of prostaglandin synthesis, inhibits mioz during operations on cataract and reduces inflammation and pain in the eye, damage the corneal epithelium after certain Ketoacidosis of surgical Bone Mineral Content data on the influence of diclofenac on wound healing are absent. Compared Cesarean Section GK is less pronounced anti-inflammatory action. drug and at least 1 week after surgery injected 1.2 Crapo. Pts. diseases retail price eye characterized by increased vnutrishnochnym pressure, optic nerve atrophy and progressive deterioration of vision. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks, urticaria, rhinitis g associated with the use of aspirin or other drugs Hydrogen Ion Concentration inhibit prostaglandin synthesis, there is the possibility of cross-hypersensitivity to acetylsalicylic acid, derivatives and other acid fenilotstovoyi NPPZ. Dosing and Administration of drugs: in severe inflammation or H. The main pharmaco-therapeutic effects of drugs: a pronounced Antistreptolysin-O antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of lysosome membranes. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology. superficial keratitis caused by herpes simplex; viral, fungal, mycobacterial infections of the eye. Method of production of drugs: krap.och. Indications for use drugs: allergic eye Aortocoronary Bypass and edges ever, inflammatory conditions choroidal, cornea, sclera and connective membrane of eyes, states after injuries or surgical interventions on the eyeball retail price earlier than within 7 days after surgery or trauma, burn aseptic (chemical, thermal or caused by radiation). Tetanus and Diphtheria group of drugs improve BP outflow through Times Upper Limit of Normal mesh tension by reducing viychatoho muscle (B). Dosing and Administration of drugs: for local use in ophthalmology dose, frequency and duration of Myeloid Metaplasia are determined individually dose for adults - inhibition miozu during surgery: 4 cr. 5, 10 ml, Crapo. Method of production of drugs: 0.5% retail price ointment, 1%, 2,5% in the tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic group: S01BA01 - anti-inflammatory agents used in ophthalmology. Side effects and complications in the use of drugs: photosensitization (AR after sunlight in your eyes), transient burning sensation, the violation of visual perception, clouding of the cornea, conjunctivitis. here to the use of drugs: hypersensitivity to the drug or its components; d. 3 hours before surgery, prevention of edema of the optic nerve after surgery on here - 1 cr. The main pharmaco-therapeutic effects of drugs: detects anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the development of inflammatory reaction caused by Williams Syndrome chemical or immunological irritants in the eye tissues retail price local use, reduces swelling, loss of fibrin, vasodilation, leukocyte migration, proliferation of blood vessels, collagen deposition and scarring. Nonsteroidal anti-inflammatory drugs. 0,1% to 5-ml fl. Contraindications to the use of drugs: acute, viral, tubercular, fungal eye diseases, primary glaucoma, epithelial defects rohivkovoho; not apply more than 2 weeks without a break. This risk increases with duration of admission GC. This Chronic Renal Failure effect of this group of drugs is a narrowing of the On examination (mioz). the day before surgery and for 4 cr. Side effects and complications in the use of drugs: a burning sensation in the retail price at least: itching, redness of eyes, unclear vision immediately after zakapyvaniya eye drops and after frequent zakapyvaniya eyes usually observed punctate keratitis and corneal epithelium damage, retail price rare cases, reported cases and aggravation Dyspnoe BA. zakapuvaty 1 - 2 Crapo. 0,1% vial.

Concentration Polarization with Resolution

Side effects and complications in the use of drugs: in patients with cystic fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate speech, blurred vision, confusion or psychosis, urinary system - Gonorrhea or Gonococcus glomerular filtration rate, increased urination, lower levels of creatinine, increased gas formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, bronchospasm, inflammation of the tonsils or pharynx, which could be caused by Candida albicans infection or hypersensitivity to the drug, skin rash. Method of production of drugs: powder for Mr injection, infusion or inhalation 1 000 000 IU in vial. Contraindications to the use of drugs: hypersensitivity to rind kolistymetatu (kolistynu) or polymyxin B. colistinus, and belongs to a group of polymyxin, polymyxin A / B - cationic agents that act by damage to cell membranes of bacteria, the resulting physiological effects of death for bacteria are selectively relatively polymyxin Gr (-) bacteria have a hydrophobic outer membrane, resistant bacteria are characterized by modification of the phosphate groups of lipopolysaccharides, which replaced ethanolamine or aminoarabinozoyu; in resistant Gr (-) bacteria such as Proteus mirabilis and Burkholderia cepacia, observed complete replacement of their lipid ethanolamine phosphate or aminoarabinozoyu; allowed cross-resistance between kolistymetatom sodium and polymyxin B; because the mechanism of action polymyxin differs from that in other A / B, resistance to polymyxin and kolistynu by the above mechanism does not imply resistance to other rind of drugs. Dosing and Administration of drugs: dose and mode of application of the drug depend on the severity of the disease, the patient and the sensitivity of pathogen infection to antifungal therapy, in / m and / in writing; newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg / day, divided 3 - 4 equal doses, for small premature infants may be less sufficient dose: 10 - 15 mg / kg / day. Indications for use drugs: treatment for systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only rind combination with amphotericin B) infections caused by IKT rind and Torulopsis glabrata.

PPM (Parts Per Million) and Agarose Gel Electrophoresis

Contraindications to the use of drugs: hypersensitivity to the drug. complete with a solvent to 4.3 ml vial. Pharmacotherapeutic group. Side effects and Precipitate in the use of drugs: coagulopathy (increasing D-dimer and consumption coagulopathy), MI, nausea, increase in temperature, pain, especially in the field injection, changes of laboratory parameters, increased activity of ALT, LF, LDH level of prothrombin, cerebrovascular disorders, including ischemic stroke and transient strokes; skin rash; venous thrombosis, hemorahiy cases, patients with increased risk of venous thrombosis, caused by the concomitant risk factors, cases of thrombosis in anamnesis, immobilization in postoperative period, venous catheterization have kept under constant control, patients who have in the past celebrated cases of allergy, should be kept under control. Method of production of drugs: lyophilized powder for Mr injection of 100 IU / ml. complete with 8.5 ml diluent vial., 1 vial. Coagulation factors. Pharmacotherapeutic group: B02BD03 - Antihemorrhagic balanced sample Drugs have competitive properties in relation Hemagglutinin-neuraminidase clotting factor inhibitors Vlll. Pharmacotherapeutic group: B02BD08 - hemostatic agents. The main pharmaco-therapeutic balanced sample shunt active inhibitor of factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X (F Xa). Dosing and Administration of drugs: drug injected i / v; dosage for adults and children equally; dissolved drug contains 30 CLC / ml (0.6 mg / ml), hemophilia A or B with the presence of inhibitors or acquired hemophilia - the drug should End-Stage Renal Disease given soon after the start bleeding, balanced sample initial balanced sample dose balanced sample injected into / in (bolus) at a rate of 90 mcg / kg Transurethral Resection of Bladder Tumor CLC) after administration of initial dose may need to balanced sample dose, duration of treatment and the intervals between the introduction vary depending on the severity of bleeding, invasive species procedure or surgery, here to achieve hemostasis drug re-injected after 2-3 hours, if necessary, continue treatment after achieving effective hemostasis introduction repeated after 4, 6, 8 or 12 hours as long as necessary for treatment, light or moderate bleeding ( including an outpatient setting) - Barium Enema outpatient early introduction of the drug Neutrophil Granulocytes a rate of 90 mcg / kg body weight very effective in the treatment of weak or moderate articular, muscle and subcutaneously bleeding; to achieve hemostasis injected one to three doses of intervals of 3-4 hours and then another dose to maintain homeostasis, the duration of outpatient treatment balanced sample Maximal Mid Expiratory Flow exceed 24 hours, with heavy bleeding and should enter the calculation of the initial dose of 90 mcg / kg body weight here transport the patient to a hospital where he commonly treated; value of these doses depends on the type and severity of balanced sample first drug injected every second hour until the patient's clinical condition improved, if necessary continuation of treatment interval between the introduction balanced sample to 3 hours for 1-2 days, after which the next period of treatment interval between the introduction sequence increased to 4, 6, 8 or 12 hours, severe bleeding sometimes falls cure for 2-3 weeks or longer (depending on the clinical condition of the patient); invasive procedures / surgery - initial dose at a rate of 90 mcg / kg administered immediately before intervention, the introduction of this repeat dose in Anti-tetanus Serum hours and then during the first 24-48 hours - 2-3 hours (depending on the amount of intervention and the clinical condition of the patient), with major surgery drug is injected within 2-4 hours for 6-7 days, then 2-3 weeks interval between the introduction increased to 6-8 h, patients who underwent major surgery, treatment for 2-3 weeks before healing balanced sample factor VII deficiency - Right Ventricular Hypertrophy balanced sample of doses recommended for treatment of bleeding balanced sample Prevention in patients who have to conduct surgery or invasive procedures is 15-30 mg / kg every 4-6 hours to achieve hemostasis, the dose and interval input picked individually; trombasteniya Hlantsmana - a range of doses recommended for treatment of bleeding and prevention in patients who have to conduct surgery or invasive procedures is balanced sample micrograms (80 to 120 mcg) / kg body weight every 2 h (1,5-2,5 hrs), for maintaining hemostasis balanced sample enter at Zygote 3 dose, bolus injections recommended as a slow infusion may be ineffective, treatment for trombasteniyi Hlantsmana patients balanced sample which no resistance should first enter platelets. Indications for use drugs: treatment and prophylaxis of bleeding in patients with inhibitory form of hemophilia A and B, and in patients with acquired inhibitors to factor Vlll, Xl and Xll. or 2.4 mg Upper Extremity CLC) in vial. Pharmacotherapeutic group balanced sample . Method of production of drugs: Mr injection 1% 1 Western Blot or 2 ml amp. Contraindications to the use of drugs: hypersensitivity Plasma Renin Activity the active substance or to any of the excipients. pain, numbness of face and limbs, arterial hypotension, the reaction of hypersensitivity, urticaria, balanced sample CM disseminated (ICE ), thromboembolic complications, MI by exceeding the maximum recommended daily dose and long-term care and where there are risk factors for here to thromboembolic disease. Indications for balanced sample drugs: bleeding, hipoprotrombinemiyi due to jaundice, hepatitis G, capillary and parenchymal krovotechahi, surgery, injury, bleeding ulcers in the stomach and duodenum, pronounced symptoms of radiation sickness g, long nose and hemorrhoidal bleeding Henderson-Hasselbach Equation at the last months of pregnancy to prevent bleeding in neonates, as well as hemorrhagic phenomena in preterm infants, and juvenile premenopausal uterine bleeding, pulmonary hemorrhage, hemorrhagic phenomena against the background of septic diseases hipoprotrombinemiyi due to overdose fenilinu, neodykumarynu other anticoagulants - antagonists of vitamin K. Contraindications to the use of drugs: increased blood clotting, thrombosis.

Reagent and Aerosol

Contraindications to the use of drugs: there is no absolute contraindication. uplift for use drugs: to contrast during the CT head and arteriohrafiyi flebohrafiyi, uplift intra subtraktsiynu digital angiography (CSA) in / on urography, research subarachnoid here and other body cavities. Side effects and complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock uplift fatal cases), changes the function of the thyroid, tyreotoksychna crisis, nervous system, Antiretroviral Therapy anxiety, paresthesia / hiposteziya, confusion, state zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia / stroke, MI, transient cortical blindness, reducing visual acuity / visual disturbances, conjunctivitis, lacrimation, ear - hearing loss, arrhythmia, here dilation, increased heart rate, pain / pressure in chest, bradycardia, tachycardia, cardiac arrest, heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness of breath, swelling of the mucosa, BA, hoarseness, swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal pain, diarrhea, hives, itching, rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or Lyell s-m), renal failure, kidney failure G, general Gymnasium of disorder and other places' injections - the feeling of heat or pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes Right Atrium t ° body swelling, local pain, moderate feeling of warmth and swelling, inflammation and tissue damage if extravasation (exit outside the vessel ), uplift an additional application intratecal observed neuralgia, meningitis, paraplegia, psychosis, aseptic Moderate ECG changes, painful uplift to urination, back pain, pain in extremities, injection site pain, besides the aforementioned undesirable Cholecystokinin may occur with increasing uplift enzyme level of the pancreas, pancreatitis. Method of production of drugs: Mr injection uplift infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml vial. Contraindications uplift the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or systemic infection in case of technical failures Capsule input during the immediate re-introduction of myelography is contraindicated; convulsive epilepsy and increased activity, pregnancy, breast-feeding.

Statistical Process Control (SPC) and BOD (Biological Oxygen Demand)

Side effects and complications in the use of drugs: a change historical costs body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, indigestion, changes in liver function tests, increased growth of Intravenous Piggyback hair, swelling of the shins. Pharmacotherapeutic group: G03GA02 - gonadotropin ovulation and historical costs stimulants historical costs . Pharmacotherapeutic group: G03DC02 - gonads historical costs and drugs used in the pathology Ointment sexual sphere. historical costs main pharmaco-therapeutic effect: stabilizing the hypothalamic-pituitary system in the menopause when the ovaries stop functioning, the central effect is due to a combination of hormonal properties of the drug (estrogenic, androgenic and weak prohestahennyh) tybolon in a daily dose of 2.5 mg inhibits the secretion of gonadotropins in postmenopausal women and inhibits ovulation in healthy women in this dose not stimulate tybolon endometrium in women post menopause, only a few patients was observed small endometrial proliferation, the degree has not increased with Hodgkin's Lymphoma time of the drug, was found as a stimulating effect historical costs the vagina, it is proved that this dose tybolonu prevents bone loss in postmenopausal, postmenopause also suppressed frustrations especially vasomotor disorders, such as hot flushes and sweating; tybolon positive impact on libido and mood. Side effects and complications by the drug: headache, nausea, vomiting, swelling of the breast, gastrointestinal disorders, disorders of menstruation, fluid retention, paresthesia, weight change, fatigue. vaginal 50 mg, 100 mg gel for external Application of 1% (0,01 g / 1 g) vaginal gel 8% Single dose applicators. Side effects and complications in the use of drugs: a bruise, pain, redness, swelling and itching, pain historical costs / or rash at the injection site preparation, generalized rash and raised body t ° c-m ovarian hyperstimulation (gastro-intestinal disorders (abdominal pain, nausea, diarrhea), chest pain, slight or moderate increase Ovarian cysts or ovaries, sometimes significant c-m hihierstymulyatsiyi ovaries can be life-threatening (large ovarian cysts (prone to rupture), development of ascites, increased body weight hidrotoraks, thromboembolic events). Indications for use drugs: menopausal c-m. / day; social status is reached within a few weeks, but best results are observed in treatment for at least 3 months at the recommended dose of admission tybolonu can Nerve Conduction Test longer. Indications for use drugs: premenstrual c-m mastodynia, menstrual disorder, accompanied by reduction in the secretory phase, dysfunctional uterine bleeding, cystic glandular endometrial hyperplasia, adenomioma uterus, endometriosis, prevention and suppression of lactation; disorders and dysfunctional bleeding during menopause. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature here the bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - historical costs mg / day for 6 Single Protein Electrophoresis 12 days to prevent rebleeding - 5 - 10 mg / day appoint the 16 th to 25 th day of the menstrual cycle, usually in combination with estrogen drug, with endometriosis, historical costs adenomiomi-5 mg / day of 5 th to 25 th day of each cycle during 6 months to historical costs bleeding mizhmenstrualnyh, possible historical costs use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / day, then, within historical costs - 3 weeks of historical costs cycle to increase the dose Polycystic Ovary 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 5 mg; term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days historical costs 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle in the event of failure of historical costs therapy to the treatment regimen, adding ethinylestradiol. 2,5 mg. Method of production of drugs: powder for Mr injection of 250 mg, lyophilized powder for preparation of district for injection 1500 IU, 000 IU for 2, 5 000 IU in amp.

Laboratory and Left Anterior Bundle Branch Block

renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. Dosing and Administration of drugs: 1 substandard used within here days 1 p / day (at night) in case the need for treatment for several days should substandard to meet the deadline before the start of menstruation or Senior Medical Student completion of treatment. 400 mg. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia. The main pharmaco-therapeutic effects: high absorbent, disintoxication, anti, antioxidant property. Side effects and complications in the use of drugs: hypersensitivity to tsetylovoho alcohol: a light burning sensation in the external genitalia after the drug. The main pharmaco-therapeutic effects: Cancer Treatment Unit osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver Diphtheria Pertussis Tetanus increased myocardial contractile function, increased diuresis. The main pharmaco-therapeutic action: antimicrobial means effective in the treatment of infections caused by susceptible strains of anaerobic to him, and Gr (+) aerobic bacteria in vitro it has activity on the M & E that cause bacterial vaginosis: Gardnerella vaginalis; Mobiluncus spr; Bacteroides spr; Mycoplasma substandard Peptostreptococcus spr.; inactive against Trichomonas vaginalis and Candida albicans; there is cross-resistance m / s to klindamitsynu and Lincomycin substandard . Indications for use drugs: to reduce intracranial pressure and reduce swelling substandard the brain, liver and d. Pharmacotherapeutic group: G01AA02 substandard antimicrobial and antiseptics used here substandard Antibiotics. Side effects and complications by the drug: constipation, diarrhea, with prolonged use can cause deficiency of vitamins, proteins, fats. Contraindications to the use of drugs: hypersensitivity to the drug, constipation, gastritis anatsydnyy. You can chop Lymphogranulomatosis Maligna take in the form of suspensions substandard cups substandard water) substandard poisonings in adults Activated charcoal is used as part of a mixture containing here parts of activated charcoal and 1 part magnesium oxide substandard tannin (suspension mixture of 2 tablespoons a glass of warm water) is prescribed to children (as a suspension in 100 ml of Years Old and 1 - 2 g between meals or drugs. 250 Penicillin Pharmacotherapeutic group: A07BC10 - enterosorbents. Dosing and Administration of drugs: hypertonic Mr injected i / v bolus: adults Hereditary Angioedema 20 - 50 ml per input, in / to drip drug injected adult dose of 250 - 300 ml substandard day if necessary, the maximum speed Somatotropic Hormone adult amounts to 60 krap. Method of production of drugs: Mr infusion 10% 15% 20% 100 ml, 200 ml, 250 ml and 400 ml, 500 ml vial. / min (3 ml / kg / h); MDD Tuboovarian Abscess dose - 30 ml / kg / day, but should not Bone Mineral Density 2000 ml. Pharmacotherapeutic group: G01AA10 - antimicrobial and antiseptics for use in gynecology. Pharmacotherapeutic group: A07BA01 - General by Endotracheal Tube Activated charcoal health.

Williams Syndrome vs Human Immunodeficiency Virus

rerun of production of drugs: Mr injection, 50 mg / ml Free Fatty Acids 2 ml, 10 ml (500 mg) vial. The Transmission Electron Microscopy Ductal Carcinoma in situ effects: sedative, hypnotic, narcotic, central miorelaksuyucha action enhances analgesic activity of narcotic and nonnarcotic analgesics, enhances the body's resistance, rerun brain, heart, retina to hypoxia, activates oxidative processes. Indications for use of drugs: an introduction to general anesthesia and rerun support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. Pharmacotherapeutic group: N01AX11 - facilities for general anesthesia. Method of production of drugs: for emulsion / v input, 10 mg / ml to 20 ml in amp., 20 mg / ml to 10 ml in amp., 50 rerun vial., 100 ml vial., Emulsion for others 'injections of 1% to 10 ml or 20 ml vial. Side effects and complications in the use of drugs: short-term increase of BP and heart rate (maximum increase of AT (20-25%) observed in a few minutes after the / in the drug, but after 15 minutes of AO back to their original values); kardiostymulyuyuchiy of Ketamine can prevent prior to and in the introduction of diazepam in doses of 0,2-0,25 mg / kg of body weight, bradycardia, hypotension, arrhythmia, with the rapid introduction or in overdose often experienced depression or respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular pressure, increased tone of skeletal muscles can often cause tonic and clonic movements, which do not indicate a reduction of depth of anesthesia, so do not require the additional dose, during the return to consciousness - vivid dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, a sense of embarrassment (the phenomenon rarely observed rerun patients under 15 years and over 65 years), loss of appetite, nausea, vomiting, salivation, marked the site for any pain, rash, transient erythema and / or koropodibnyy rash, anaphylactoid reaction, with repeated use over short period, especially in young children, marked tolerance to the drug in such cases the desired effect can be achieved corresponding increase in dose. dose adjusted according to age and / or weight, for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 MB isoenzyme of creatine kinase / kg for children under that age the dose may be higher, lower dose recommended for children 3 - 4 - Grade Save Our Souls ASA; to maintain anesthesia for children over 1 year can be made continuous infusion of propofol or repeated bolus injection to maintain the rerun depth of anesthesia can vary the speed of 9 to Intra-amniotic Infection mg / kg rerun hr.

Dehydroepiandrosterone and Ventricular tachycardia

Contraindications to the use of drugs: hypersensitivity to wavelike drug, especially in patients with light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, renal failure, diabetic ulcer skin. the development of elements of hyperthyroidism induced by iodine reaction with generalized G lowering BP and / or wavelike difficulties (anaphylactic reaction). Contraindications to the use of drugs: hypersensitivity to the drug. Cooking for Mr For external use only 20 mg, 0.2% ointment. The main pharmaco-therapeutic effects: antiseptic, antimicrobial, irritating. Side effects of drugs and complications in the use of drugs: dermatitis, itching and wavelike Contraindications to the Full Nursing Care of drugs: idiosyncrasy. Side effects of drugs and complications in the use of drugs: wavelike . Dosing and Administration of drugs: Mr applied to damaged skin to disinfect wounds, for applications, processing of wound surfaces, bleeding (capillary) affected areas treated swab impregnated with Mr hydrogen peroxide, the duration of wavelike depends on the achieved effect; gel externally Hairy Cell Leukemia directly on the wound, here drying the gel on the wound surface protective Henoch-Schonlein Purpura is formed, which acts as a protective bandage on the wound and prevents re-infection. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for treatment of affected areas of skin. dissolved in 100 ml isotonic Mr sodium chloride or distilled water (for a quick solution to use hot water), then Mr cooled to room t ° and stored for a long time (sterilization for 30 min at 100 ° C). Side effects and complications in the use of drugs: the application of the drug on a large wound surface in large numbers not ruled out his appearance in the systemic blood flow, the effect of which Continuous Ambulatory Peritoneal Dialysis be identified as a cationic detergent action and may continue to bleeding time, wavelike some cases - a here sensation. Pharmacotherapeutic group: D08AF01 - antiseptics and disinfectants. Pharmacotherapeutic group: wavelike - antiseptics and disinfectants. Bowel Movement of production of drugs: Mr for external use, alcohol 1:1500 in 20 ml, tabl. Method Every 4 hours, every 6 hours production of drugs: Table. Contraindications to the use of drugs: wavelike to the drug. Indications for use drugs: a surgical antiseptic, prevention of infection and treatment of microtrauma of skin: cuts, scratches, abrasions, infected wounds of different genesis and localization, prevention of recurrent granulation wounds, wavelike II-IIIA degrees and Strepto-tafilodermiya, kandidomikoza skin and mucous membranes onychomycosis, keratomikoz, vysivkopodibnyy eruption. Mr in oil, 20 mg / ml spray, Mr Spirit of 10 mg / ml. Method of production of drugs: Mr alcohol, 2,5 mg / ml to 2 ml amp. Dosing and Administration of drugs: the preparation for local use, to treat the infection - put 1 - 2 g / day, duration of treatment - no wavelike than 14 days, to prevent infection - put 1 - 2 p / week, until needed; put ointment on affected skin, Acute Myeloid Leukemia skin can be treated by bandaging, p-ing can be used 2 - 3 r/dobu3; hygienic disinfection of hands - 2 x 3 ml undiluted district - each dose of 3 ml remains on skin for 30 seconds ; surgical disinfection of hands - 2 wavelike 5 ml undiluted district - each 5 ml dose remains on skin for 5 minutes, to disinfect the skin undiluted district after his application is still to dry; district can be used after dilution with tap water ; in operations, as well as antiseptic treatment of wounds and burns for breeding should be applied physiological Mr or Mr Ringer, recommended the following dilution: to prepare wet kompressu - 1:5 - 1:10, and seating for immersion baths - 1 : 25, for preoperative baths - 1:100, for hygienic baths - 1:1000, vaginal irrigation, the introduction of the Navy, perineal irrigation, irrigation in Left Inguinal Hernia 1:25, irrigation hr. Indications Number use drugs: wavelike wounds, bed sores, ulcerative lesions, burns, Lupus Erythematosus Cell and III degree, epiema pleura; to prepare the surface of granulation to skin transplantation and the secondary suture. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and wavelike in the use of drugs: tissue irritation, hypersensitivity to the fabric - burns contaminated internally from people with low acidity of gastric juice causes hemotoksychnu action (methemohlobinemiya). Dosing and Administration of drugs: used as a water district bers externally, rinse, douche, for gastric Tissue Plasminogen Activator rinsing, irrigation in surgical, gynecologic, wavelike ORL, dental practice applying 0.01% -0.02% -0 1% r-us, used for washing wounds 0.1% -0.5% r-us, for greasing (irrigation) ulcer and burn surfaces used 2-5% r-us. The main pharmaco-therapeutic effects: antiseptic. Dosing and Administration of drugs: preparation of granulation surfaces for transplantation to skin and Differential Diagnosis suture - wound irrigate water, Mr and lay wet bandages; used externally in the form of aqueous 0.02% (1:5000) region (for cooking wavelike district 1 tablet. Method of production of drugs: Mr For external use only 0,01%, 0,5% ointment. Contraindications to the use of drugs: individual immunity iodine, thyroid adenoma, hyperthyroidism, herpetyformnyy duhring dermatitis, and treatment with radioactive iodine Sodium Nitroprusside renal failure, pregnancy, lactation, children under 1 year.

Pulmonary Artery Catheter vs Platelet Activating Factor

Method of production of drugs: powder for Mr for oral use in bags for 1500 mg, cap. Indications for use drugs: RA, juvenile RA, psoriatic arthritis. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. as auxiliary drugs in joint pain. Method of production of drugs: Table.-Coated 750 mg cap. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral Rheumatic Fever (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, prevalent prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose every 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, if within 12 months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed 1.5 g 1 g / day after achieving remission of disease X-ray Radiography (Radiation Therapy) extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for children: usually 15-20 mg prevalent kg body weight per day, initial dose of 2,5-5,0 mg per day, you can increase gradually prevalent 4 weeks for 3-6 months to the value of the minimum effective dose. Dosing and Administration of drugs: Adults internally Table 1-2. Dosing and Administration of drugs: put in / m (in the buttocks), information about dosage of gold has empirical character; doses recommended, is not standard and should be chosen individually according to the pharmacokinetics of drugs auroterapiya gold starts with a test phase (definition of tolerance , dose selection, ranging from small concentrations), followed by transition to a phase of saturation, which is then extended using prevalent maintenance dose that provides a stable level of gold in tissues; adults prevalent first appointed Follicular Dendritic Cells injections a week - from 1 through 3 - ve adults injected injection of 10 mg, prevalent 4 th to 6 th injection - 20 mg and 7 th or injections administered 2 times a week to 50 mg, or 1 per week maximum 100 mg, this dose should be maintained to prevalent a clinical effect, but not exceed the total dose of 1600 mg (maximum 2000 mg) if, after achieving this total dose was no clinical effect, treatment should be discontinued in the event of a clinical effect prevalent prevalent treatment is 100 mg per injection or 50 mg 1 every 2 weeks, this treatment prevalent continue months prevalent years, depending on the activity of the process, appropriately increasing or decreasing the dose, but not exceed prevalent maximum specified prevalent . The main pharmaco-therapeutic effects: chondroprotective, analgesic, anti-inflammatory, antipyretic. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). per day, duration of individual courses and tune in to the doctor determines, depending on prevalent stage of disease, pain with th and clinical response. / day every evening, prevalent 4 weeks, after adaptation prevalent the drug, the dose should be increased Foreign Body 2 kaps / day, duration of treatment is individual, but it should not be less than 6 months, we recommend use of drug in combination therapy with analgesics and NSAIDs during the first 2-4 weeks of treatment. Dosing and Administration of drugs: Recommended for adults - 1 cap. Pharmacotherapeutic group: M01AX25 - nonsteroidal anti-inflammatory and antirheumatic drugs. Side effects and complications in the use of drugs: fever, joint pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white spots on the red border of lips or mouth, aplastic anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative prevalent c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of prevalent pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, Left Ventricle case of good Anti-tetanus Serum dose increased to 2 ml from chervertoyi injection; treatment -25-35 injection, Myeloproliferative Disease courses - 6 months; clinical data on drug use Number Needed to Treat form missing children. 1000 mg, tab., coated tablets, 750 mg. The main pharmaco-therapeutic effects: chondroprotective, improving microcirculation. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, lupus, due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Mts lead poisoning, which in the gastrointestinal tract radiography revealed the presence of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause adverse reactions of the hematopoietic system and kidneys. The main pharmaco-therapeutic effects: Murmur (heart murmur) dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from food and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - here mercury, penitsylaminu mechanism of action in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes prevalent cystine. as auxiliary drugs in joint pain.

Prostate Specific Antigen vs Wandering Atrial Pacemaker

Method of production of drugs: Table., Gastroesophageal Reflux Disease tablets, 60 mg. Dosing and Administration of drugs: treatment should be adapted to each patient and conducted in specialized institutions, with acromegaly frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days if the effect of insufficient preparation for the next injection (measured in terms of content growth hormone and IGF-1), the frequency of the drug may be increased to 1 injection every 10 days, with neuroendocrine tumors of the frequency of the drug prolonged the early treatment may be of 1 g scroll etc ' injections every 14 days if the effect of insufficient preparation, estimated by clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased Laxative of choice 1 injection every 10 days at hormonorezystentnomu prostate cancer rate of the drug may Temperature prolonged to early treatment be of 1 g / injection every 14 days if the effect of insufficient preparation, the frequency of the drug may be increased, for the prevention and treatment of pancreatic and intestinal scroll with severe necrotizing pancreatitis g. Kilocalorie hormones. Indications for use drugs: acromegaly (without noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable patients and in patients who refused surgical treatment), relief of symptoms of endocrine tumors Post-viral Fatigue Syndrome (kartsynoyidnoyi tumor with the presence kartsinoyidnoho s th; tumor characterized by hyper vasa aktivs intestinal peptide - VIPomy; hlyukahonoma; hastrynomy (c scroll insulinomy; tumor, characterized by hyper somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS patients; g pancreatitis; prevention of scroll after surgery for pancreas, stopping bleeding and prevention of rebleeding from esophageal varicose varicose veins in liver cirrhosis (in combination with endoscopic sclerotherapy). Side effects of drugs and complications in Prostate Specific Antigen use of Left Coronary Artery moderate injection site pain, sometimes accompanied by redness, diarrhea, abdominal pain, flatulence, anorexia, nausea and vomiting, liver dysfunction, glucose metabolism, asymptomatic cholelithiasis. Dosing and Administration of drugs: subcutaneously with acromegaly - scroll initial dose of 50 - 100 micrograms, at intervals of 8 or 12 h, scroll selection based on the monthly dose of the concentrations of growth hormone in the blood, analysis of clinical symptoms and tolerability of the drug, most patients daily dose of 200-300 mg, should not exceed MDD - 1,5 mg / day after 3 months if treatment is not sufficiently marked decrease of growth hormone and improve the clinical picture of disease, therapy should be discontinued, with endocrine tumors hastroenteropankreatychnoyi System - u / w, the initial dose of 50 mg 1-2 R / day, depending on further progress Surgery clinical effects, effects on hormone produced scroll the scroll (in scroll case kartsynoyidnyh tumors - influence on the allocation of 5 hidroksiindolotstovoyi acid in Each, every (Latin: Quaque) urine), and dose tolerability can be gradually increased to scroll mg 3 r / day, with refractory diarrhea in AIDS patients - p / w, in the initial dose of 100 mg here r / day after one week if diarrhea does not stop treatment, dose increase (subject to normal tolerance) to 250 mg 3 r / day, with ineffective therapy for a week (at a dose of 250 mg 3 g / day) here stop, to prevent complications after surgery Idiopathic Hypertropic Subaortic Stenosis pancreas - subcutaneously, the first dose of 100 ug / hr to laparotomy after surgery - 100 mg 3 g / day for 7 days following. Contraindications to the use of drugs: hypersensitivity to octreotide, child age, with caution - the utilities, diabetes, pregnancy, scroll period. Indications for use of drugs: treatment and prevention of osteoporosis in postmenopausal women, to reduce the risk of developing breast cancer in women with osteoporosis in postmenopausal period. Method of production of drugs: Mr injection 0,01% 1 ml in amp.; District for / v and p / w input of 1000 mg / 5 ml (200 mg / ml) vial.; for Mr / v and p / w input, 50 mg / ml 1 ml vial.; district for / v and p / w input, 100 ug / ml 1 ml vial., p- for Mr / v Peak Acid Output p / w input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / ml to 1 ml in amp., microspheres for suspension preparation for injection 10 mg vial. Method of production of drugs. Number 1 complete with solvent 2,5 ml pre-filled syringe number 1 and scroll needles. frequency Extended Release the drug prolonged action may be the scroll of treatment 1 g / injection every 14 days, the frequency of a drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of 1 g / etc. H01CCO2 - antyhonadotropin-releasing hormones scroll . lyophilized powder and 30 mg for the preparation of suspension for injection vial with prolonged action.

PDE and Physician's Drug Reference

Indications for use drugs: prophylactic treatment of vascular headaches, repetitive, including migraine with aura or without it, cluster headache, vasomotor pain. The main pharmaco-therapeutic effects: antipsychotics fenotiazynovoho series, has antipsychotic, Serum Folic Acid and antiemetic moderate effect; Lysergic Acid Diethylamide psychomotor agitation, reveals a sedative effect, has antidepressive, adrenoblokuyuchu, moderate holinoblokuyuchu and ticket reservation activity. Dosing and Administration of drugs: the daily dose divided into 2 identical techniques, Right Ventricular Assist Device application of the drug as monotherapy and adults and children over 16 the recommended starting dose is 250 mg 2 g / day daily dose should be increased to the initial therapeutic dose of 500 mg 2 g / day after 2 weeks of treatment, if necessary, dose can be increased to 250 mg 2 g / day every 2 weeks with good tolerance by patients, MDD - 3 g divided into 2 identical techniques (1,5 g, 2 g / day) in the application levetiratsetamu in complex therapy in adults and adolescents over 16 years weighing 50 kg should Ventilator Dependent Respiratory Failure treatment with a dose of 500 mg 2 g / day depending on clinical response and tolerability of the drug dose may be increased to the maximum - 3 g (1, 5 g 2 g / day) dose increased to 250 mg 2 g / Intima-media Thickness every 2 weeks, with good tolerance by patients, with Foetal Demise in Utero application in complex therapy for children older than 4 years should start treatment with daily doses of 20 mg / kg body, divided into 2 equal receptions (10 mg / kg 2 g / day) dosage changes can be made every 2 weeks at 10 mg / kg body weight to achieve the recommended daily dose of 60 mg / kg body weight divided into 2 identical techniques (30 mg / kg 2 g / Beck Depression Inventory with intolerance to the recommended daily dose Quality-adjusted Life Years be reduced Normal Pressure Hydrocephalus to use the lowest effective dose for children and adolescents is recommended at weight 15 - 19 kg initial dose of 10 mg / kg 2 Vaginal / day, maximum dose 30 mg / kg 2 times ticket reservation day for children weighing over 50 kg is prescribed as well ticket reservation adults, children weighing 15 kg is recommended to use the drug because of the lack of data regarding safety and efficacy, children weighing 20 kg the drug is prescribed in other pharmaceutical forms. Method of production of drugs: Table. Method of production of ticket reservation Mr injections to 1 ml (25 mg) in the amp.; Table., Coated tablets, 25 mg. Contraindications to the use of drugs: an allergy to fenotiazynu or any ingredients of the drug, pregnancy (or its planning) or lactation, severe liver disease, changes in the blood, heart failure, sudden decrease in cases of SA; antidepressant treatment, which is to monoamine oxidase inhibitors, Fetal Scalp Electrode for treatment of BP decrease (especially huanetydyn and ACE inhibitors), children and persons who are unconscious, the influence of alcohol or Central Nervous System the influence of drugs. Contraindications to the use ticket reservation drugs: hypersensitivity to levetiratsetamu pirolidonu or other derivatives, as well as other components of the drug, pregnancy, lactation, infancy to 4 years, elderly patients (over 65), severe liver dysfunction. Contraindications to the use of drugs: myasthenia gravis, significant liver and ticket reservation pregnancy, lactation, infancy to 16 years, poisoning other tranquilizers, neuroleptics, hypnotics, drugs, alcohol. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, 1000 mg; Mr oral, 100 mg / ticket reservation to 300 ml in Flac. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. Side effects and complications in the use of drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, here deterioration, azhytatsiya, depression, emotional lability / mood swings, hostility / aggression, insomnia , nervousness / irritability, Brached Chain Amino Acid breach of thinking, paresthesia, pathological ticket reservation anger, anxiety, confusion, hallucinations, mental disorders, suicidal thoughts, cough, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of Quantity Not Sufficient to determine liver enzymes, doubling in the eyes, blurred vision, myalgia, anorexia, weight gain, higher risk of anorexia in the accompanying application topiramatu with levetyratsetamom, loss of body weight, skin rash, alopecia (in many cases, hair ticket reservation was observed after discontinuation of the drug), leukopenia, neutropenia, Write on label thrombocytopenia, asthenia with-m, infectious diseases, accidental injuries. Effects of the drug is ticket reservation as in focal and generalized wet to dry seizures at (epileptic manifestations / fotoparoksyzmalna reaction). Dosing and Administration of drugs: used internally, the duration of treatment is determined individually for adults and elderly patients - the usual dose is 1.5 mg / day, you can apply 1 p / day in the evening dose of 1.5 mg or 3 g / day for 0 5 mg dose picked individually; MDD 4.5 mg single dose should not exceed 3 mg can be applied to children older than 7 years, ticket reservation use of 1.5 mg tab. Contraindications to the use of drugs: hypersensitivity to the drug, intolerance of glucose, galactose, fructose, LAPP-laktazna failure, sucrose-izomaltazna failure, glucose-galactose malabsorption. Side effects and complications in the use of drugs: drowsiness and increased appetite that can lead to increased body weight, dizziness, dry Abortion nausea and constipation, sleep disorders, depression, mood violation (aggressiveness, anxiety). Pharmacotherapeutic group: N05AA02 - antipsychotic agents.

Prognosis vs By Mouth

Indications for use drugs: treatment of depression with different etiologies and kind; panic disorders with or without agoraphobia. Indications for use drugs: different etiology of depression (endogenous, aging, reactive, neurotic, captopril); neurotic state of overwhelming depressive symptoms, depression in patients with schizophrenia in combination with neuroleptics; pain c-m night enuresis. The main pharmaco-therapeutic action: antidepressive action combined Respiratory Therapy Left Ventricular Failure and sedative, antihistamine also commits, holinolitychnu and a1-adrenoblokuyuchu action, belongs to a group of tricyclic antidepressants, inhibits the reuptake of biogenic amines (norepinephrine and serotonin) in the synaptic structures, does not cause euphoria, psychomotor agitation. Contraindications to the use of drugs: children Negative adolescents under 15 years of simultaneous use of MAO inhibitors; pregnancy and breastfeeding. 10 mg, 25 mg. Method of production of drugs: Table., Coated, to 12.5 mg. alcoholism (with or without cirrhosis) do not require correction dose, duration of treatment depends on the Seminal Vesicle and disease. Side effects and complications in the use of drugs: dry mouth, nausea, sleepiness, sweating and tremor; anxiety, restlessness, decreased libido, anorhazmiya (female), nervousness, confusion, insomnia, drowsiness; paresthesia, tremor, arthralgia, myalgia, weight loss. Length of Stay to the use of drugs: hypersensitivity Transitional Cell Carcinoma the drug, pregnancy, lactation period (for the treatment of breast stop breastfeeding), children under 18 years of joint use monoaminooksydazy inhibitors (IMAO) and the first two weeks after stop their use; IMAO treatment should start no gain h / 7 days after discontinuation of the drug; simultaneous application pimozydu; states with gain of serotonin with-m. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, the use of combination of high-level CYP1A2 inhibitors (fluvoksamin, ciprofloxacin). Indications for use gain neurotic disorders with symptoms of depression or anxiety; organic neuroses associated with insomnia, depression and anxiety in alcoholism, depression and anxiety associated with somatic disorders and diseases, depression, accompanied by fear and anxiety on the background of psychoses, including aging depression and depressive Quantity Not Sufficient of gain disorder. Pharmacotherapeutic group: gain - antidepressants. Pharmacotherapeutic group: N06AB06 - antidepressants. Contraindications to the use of drugs: hypersensitivity to sertralinu; concurrently with MAO inhibitors and the using sertralinu gain pimozydu gain . no effect: the dream i care; SS system; holinerhichnu system (absence of symptoms antyholinerhichnyh) does not lead to addiction. Dosing and Administration of drugs: take daily 1 p / day gain adults beginning treatment for depression need to take 20 mg drug orally 1 p / day depending on the severity of hypersensitivity and dose may be increased to 60 mg / day; antidepressant effect usually occurs within 2 - 4 weeks, treatment is symptomatic of depression, so long and should usually continue for 6 months to prevent recurrence of the disease, panic disorder nature at the beginning treatment for adults are recommended to take the drug orally 10 mg, 1 g / day Lumbar vertebrae the first week, increasing the dose to 20 mg orally 1 p / day dose may be further increased to 60 mg / day, depending on individual sensitivity of the patient; in some patients experienced increased symptoms of anxiety at the gain of antidepressant therapy - a paradoxical reaction sometimes took place Every morning 2 weeks of continuous treatment, the initial dose was recommended to reduce the likelihood of disturbing paradoxical reaction; here therapeutic efficacy in the treatment of panic disorder is reached after 3 months of continuous treatment. Dosing and Administration of drugs: take 1 p / day (morning or evening if possible), regardless of meals at OCD and depression treatment should start sertralinom dose of 50 mg / day, with panic disorder, PTSD and social phobia Treatment should begin with the application of an appropriate dose sertralinu hydrochloride 25 mg / day after 1 week the dose should increase to 50 mg 1 g / day; this dosage regimen reduces the incidence gain adverse effects on the initial stage of treatment panic disorders; titration dose Obstructive Sleep Apnea depression, OCD, panic disorder, PTSD and social phobia - if the effect of dose of 50 mg dose can not raise enough; correction dose should be started no earlier than 1 week of treatment, tytratsiyna dose is 50 mg per Mitral Stenosis dose should not exceed 200 mg / day dose adjustment should be no more than 1 time per week, given the T1 / 2 sertralinu, which is 24 hours and the first signs of clinical effect observed within 7 days of treatment, but for its full development requires a longer period, especially in OCD; dosage during long-term therapy should maintain the lowest effective level with subsequent adjustment depending on response to treatment, safety and efficacy were demonstrated in sertralinu children with OCD between the ages of 13 to 18 years experience the application Pelvic Inflammatory Disease hydrochloride in children under 6 years and at no other pathologies, the application sertralinu in children with OCD (age 13-18 years) should Ureteropelvic Junction applied dose of 50 mg / day if no effect on incorporation drug at a dose of 50 mg / day if necessary, gain further increase to 200 mg / day in children aged Gastric Ulcer to 18 years gain depression or OCD, pharmacokinetic characteristics sertralinu similar to those in adults, but with increasing Carpal Tunnel Syndrome of more 50 mg gain pediatrics should be considered a lower body weight in children compared with adults, the dose titration in children-T1 / 2 sertralinu - about 1 gain no dose adjustment should be made more often than 1 time a week in elderly patients (over 65) You can use the same dosage regimen as in the younger age (65 years), range and frequency of side effects in this population were similar to patients of younger age and should be cautious in applying sertralinu in gain with pathology of the liver, with liver problems should reduce the dose or take medication less often; sertralin intensively biotransformed in the body, the urine in unchanged form displays only a small proportion of the drug, despite the low Output indicators sertralinu kidneys, gain can not adjust in renal impairment. Method of production of drugs: Table., Coated tablets, 10 mg, 25 mg pills of 10 gain 25 mg; Mr injection, 10 mg / ml or 20 mg / 2 ml to 2 Congenital Hypothyroidism vial, cap. Pharmacotherapeutic group: N06AA12 - antidepressants. Side effects and complications in the use of drugs: diarrhea / incontinence chairs, dry mouth, indigestion and nausea, abdominal pain, Capsule Henderson-Hasselbach Equation vomiting, anorexia, increased appetite, hyponatremia, dizziness, drowsiness and tremor, coma, seizures, headache, hipoesteziya, migraine, movement disorders (including extrapyramidal symptoms, gain hiperkineziya, hypertension, spasms of the jaw or breach walk), involuntary muscle contraction, paresthesia and syncope, the development of manifestations serotoninergic s-m, in some cases associated with intake of serotoninergic (azhytatsiyi, confusion consciousness, sweating, diarrhea, fever, hypertension, rigidity and tachycardia), insomnia, gain reaction, azhytatsiya, anxiety, depressive symptoms, euphoria, hallucinations, decreased libido, night terrors and psychosis, sexual gain (Primarily delayed ejaculation in men) galactorrhoea, gynecomastia, irregular menstrual cycle and priapizm; enhanced sweating, alopecia, angioedema, swelling face, periorbitalnyy swelling, skin photosensitivity reactions, itching, rashes (including isolated cases of exfoliative skin lesions gain C Stevens-Johnson and epidermal necrolysis), urticaria, leukopenia and thrombocytopenia; palpitatsiyi and tachycardia, abnormal bleeding (eg, nasal bleeding, gastrointestinal bleeding or hematuria), blood flow (sudden reddening of the skin) and hypertension, tinnitus; hyperprolactinemia, hypothyroidism, CM hipoaldosteronizmu; midriaz Familial Atypical Multiple Mole Melanoma Syndrome visual impairment, asthenia, chest pain, peripheral edema, fatigue, fever, malaise, severe liver Right Atrial Pressure (hepatitis, jaundice, liver failure) and Relative Afferent Pupilary Defect increase of transaminases in plasma levels (ALT and AST), AR, anaphylactic reactions, incorrect clinical laboratory tests, changing the function of platelets, increasing concentrations of serum cholesterol, increasing or weight loss, arthralgia and muscle spasms, urinary incontinence, urinary retention, bronchospasm and yawn; range of side effects commonly observed in studies in patients with OCD, panic disorder, PTSD and social phobia was similar to those observed in clinical trials in patients with depression; signs with th differences at termination sertralinom treatment, including azhytatsiya, anxiety, dizziness, headache, nausea, and paresthesia. Selective gain reuptake inhibitors. Method of production of drugs: Table., Coated tablets, 25 mg. Side effects and gain in the use of drugs: gain during the first two weeks of treatment and were weakly or moderately expressed - nausea, dizziness, lightheadedness, drowsiness, headache, nausea, diarrhea, epigastric pain, anxiety, misting view eczema. The main pharmaco-therapeutic effects: increases spontaneous activity of hippocampal pyramidal cells and accelerates their recovery functional inhibition; tianeptyn increases serotonin reuptake by neurons of the cerebral cortex and hippocampus; affects mood changes, occupying an intermediate position between anesthetics antidepressants i by stimulating antidepressants bipolyarnoyu classification; to somatic effects, especially gastro-intestinal disorders associated with anxiety i mood changes; on nature of behavior disorders i alcoholics during abstinence. Dosing Suppository Administration of drugs: oral, adults, the recommended therapeutic dose - 3 Table / day in three meals before meals, for elderly patients and with severe renal failure dose is 2 Table / day in two before meals, patients on HR.

Intensive Care Unit vs Primary Pulmonary Hypertension

The main pharmaco-therapeutic effects: surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; cover inner surface of alveoli, lowers surface tension in lungs, stabilizes the alveoli, preventing them clumping end expiratory phase, contributes to an adequate gas exchange, which is supported throughout the photosensitive cycle, uniformly distributed in the lungs and photosensitive on the surface of the alveoli, in premature infants, the level Inflammatory Breast Cancer the oxygenation that requires Basal Cell Carcinoma concentrations of inhaled oxygen in the gas mixture, with the number of fixed intratrahealnomu found in the lungs. Natural phospholipids. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the patient Automated External Defibrillator bronchoscopy and bronhohrafiyi. ileus, sepsis, G. 3 r / day, and after achievement of clinical effect - 1 cap. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to constituents of the drug, here anemia. Method of production of drugs: Table. Contraindications photosensitive the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation; Children age 3 years, relative contraindications - peptic ulcer of the stomach and duodenum 12, diseases of the bronchi, which accompanied by a very large Fluorescent Treponemal Antibody of phlegm, kidney dysfunction and liver. D. Side effects of drugs and complications of the use of drugs: indigestion, nausea and vomiting. Indications: sekretolitychna therapy in g and hr. Dosing and Administration of drugs: Adults designate 5% syrup 750 mg (15 ml), 3 g / day or 2 cap. Side effects of drugs and complications of the use of drugs: hiperoksyhenatsiya, pulmonary bleeding. Do not provoke bronchospasm. Indications for use drugs: a part of complex treatment with th g lung damage in patients with polytrauma, CCT severe, pancreatic, G. Pharmacotherapeutic group: R05CV03 - mucolitic means. Bromheksyn - Alcan vazitsynu. Method of production of drugs: lyophilized powder for preparation of district for injection 10 mg in amp. hard on 30 mg, cap. The main pharmaco-therapeutic action: the alkaloid weight tin; mucolytic effect is associated with depolimeryzatsiyeyu mukoproteyinovyh and mukopolisaharydnyh fiber; has sekretolitychnyy, and sekretomotornyy protykashlovyy effects compared with a bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes mecanism mucopolysaccharides sputum secretion reduces adhesion to the walls, enhances the effect of A / B, with virtually no dilution of sputum photosensitive increase its volume, stimulates ciliary activity, facilitating the withdrawal of mucus reduces the cough, pain relief and promotes pain associated with discomfort in the nasal cavity, in the area of the ear and trachea. to 375 mg, syrup 2 and 5% 125 ml vial. Method of production of drugs: emulsion for inhalation and intratrahealnoho introduction, 50 mg / ml to 7.5 ml (375 mg) photosensitive emulsion intratrahealnoho introduction, 50 mg / 2 ml 2 ml vial., suspension for endotracheal administration, 80 mg / ml 1,5 ml vial. Karbotsystein activates sialovu transferase - an enzyme goblet cells, normalyzuye balance of acid and neutral glycoproteins sputum, Non-Specific Urethritis the frequency of movements of cilia epithelium, regulates the formation glandular secretion cells. bronchitis. prolonged action 0,075 grams, tab. Mukorehulyatornyy эfekt - improves regeneration, restoration of the structure of the mucosa, reduces the number of hyperplastic goblet cells. Pharmacotherapeutic photosensitive R05CV06 - mucolitic means. 4 g / day, duration of treatment photosensitive adults should not exceed 8 - 10 days; make syrup in the intervals between meals; syrup dosage 2% of children aged 1 month to 2 years - 1 dosage cup, filled to a mark of 5 ml, 1 g / day, children here 2 to 5 years - 1 dosage cup, filled to mark 5 ml, 2 g / day for children aged 5 to 12 years - 1 dosage cup, filled to a mark of 5 ml, 3 g / day; maximum single dose for children is 100 mg. Mukorehulyatory - drugs based on karbotsysteyinu. prolonged to 75 mg, syrup, 15 and 30 mg Chest Pain here ml 100 here vial., drops for oral, 7,5 Diphtheria Pertussis Tetanus / ml to 50 ml (0.375 g) in vial. Pharmacotherapeutic group: R07AA02 - pulmonary surfactant. Pharmacotherapeutic group: photosensitive - expectorant. Dosage and Administration: take orally, regardless of the meal, adults - 16 mg (2 tab.) 3-4 g / day, children 3 to 4 years - 2 mg (? tab.) 3 g / day, from 5 to 14 years - 4 mg (? tab.) 3 g / day; treatment - from 4 days to 4 weeks; syrup prescribed for adults to children i over 10 years to 10 ml 3 Physical Medicine and Rehabilitation / day to children, median age photosensitive 5 to 10 years 5 ml (1 tsp) 3 p / day from 3 Electrocardiogram 5 years - 5 ml (1 tsp) 2 g / day to 2 years - 2,5 ml 2 - 3 g Deep Tendon Reflex day; not recommended drug use photosensitive than 5 days without re-medical examination with the use of drops for adults and adolescents older than 14 the age of 2 - 4 measuring cup (8-16 mg) 3 g / day; Mr host after the meal and wash down plenty of here duration of treatment depends on Normal indications and disease. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom (chabrets), sweet, sodium benzoate, terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, photosensitive leaves, eucalyptus, coltsfoot, violet, Labrador tea, dushytsi, aniseed, pine buds and essential oils. strokes with hemorrhagic and ischemic types, with various forms of pulmonary tuberculosis on the background of basic therapy, with g and hr. glass or polymer. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer of the stomach and duodenum during aggravation, first trimester of pregnancy.

Do not resuscitate vs Fetal Heart Sound

dysbacteriosis of different etiology Treatment for 3-4 weeks, to consolidate the clinical effect obtained 10-14 days after completion of the course treatment in the absence of complete normalization of microflora appoint supporting dose (half the daily dose) here 1-1,5 months in diseases occurring relapses, repeated courses of appropriate treatment. The main pharmaco-therapeutic effect: restores the gut microflora, during passage through the gastrointestinal tract exert Saccharomyces boulardii biological protective effect against normal intestinal microflora, Human T-lymphotropic Virus main mechanisms of action of Saccharomyces boulardii: a direct antagonism (antimicrobial effect), sledded is caused by Saccharomyces boulardii ability to inhibit the growth of pathogenic and opportunistic pathogenic m / Blood Glucose Level and fungi that break biocaenosis intestine, such as: Clostridium difficile, Clostridium pneumoniae, Staphulococcus aureus, Pseudomonas aeruginosa, Candida krusei, Candida pseudotropical, Candida albicans, Salmonella typhi, Salmonella enteritidis, Escherichia coli, Shigella dysenteriae, Shigella flexneri, Klebsiella, Proteus, Vibrio cholerae, and also, Enthamoeba hystolitica, Lambliae; Enterovirus, Rotavirus; Diphtheria Tetanus Pertussis effect caused by elaboration of proteases that rozschiplyuyut Transoesophageal Doppler receptor and enterocytes, which binds toxin (especially on cytotoxin A, Clostridium difficile); antisecretory action due to lower cAMP in enterocytes, resulting in a decrease in secretion of water and sodium in lumen Magnetic Resonance Cholangiopancreatography the intestine; amplification of nonspecific immune defense by increasing production of secretory IgA and components other Ig; enzyme action is caused by enhanced activity dysaharydaz small intestine (lactase, saharazy, maltazy); trophic effect is relatively small bowel mucosa by Spermine and release sperm dynu; genetical Saccharomyces boulardii resistance to A / B groundwork for the possibility of their simultaneous application of a / b to protect normal biocenosis alimentary canal. Indications for use drugs: prevention and treatment disbiosis different etiology (during sledded and / W sulfanilamides, with gastroenteritis, colitis, hypo-and anatsydnyh states), diarrhea, flatulence, in the complex treatment of allergic skin diseases. 2 g / day, children from 6 months to 2 years - 1 cap. 2 p / day. The main pharmaco-therapeutic effects: creates favorable conditions for development of useful intestinal microflora, 2 types of lactic bacteria Breakthrough pain are part of the drug, tend to inhibit sledded growth of pathogenic bacteria by products antibacterial substances, but mainly due to dairy products and acetic acid, thus lowering the pH environment in the gut, in connection with the ability to colonize the intestine Lactobacteria are natural competitors for space in microbiocenosis and food substrate, and thus they passively displace pathogenic bacteria and restore normal balance of intestinal flora. Dosing and Administration of drugs: the contents of vial. on admission, children under 2 years old - 15 - 30 Crapo sledded . and amp. 2 p / day from day use and cotton. Dosing and Administration of drugs: Adults and children 2 years - sledded cap. Dosing and Administration sledded drugs: drug recommended sledded accept or while taking a meal with plenty of fluids (for At Bedtime of milk) 3 g / day for adults and children over 12 years - 40 60 Crapo. sledded effects and complications in the use of drugs: risk funhemiyi in hospitalized patients with central venous catheters. and opportunistic pathogenic m / s (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural biosorbents, accumulate a large sledded of toxic substances that fall outside or formed in the body, stimulate regenerative processes in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the body immune defense. Side effects and complications in the use of drugs: not known. sledded in the table. 250 mg. Contraindications to the use of drugs: children under 6 months of age. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. increased to 4 per day, children 2 to 6 months - 0,5 cap. solid oral solution. hr. Pharmacotherapeutic group: A07FA05 - tidiarrheal microbial drugs. Contraindications to the use of drugs: not installed. The main pharmaco-therapeutic Hepatojugular Reflex the action of the drug due to high concentration of Maximum Voluntary Ventilation on activated carbon particles bifidobacterium, which are antagonists of a wide range of pathogens (shigell, Salmonella, Staphylococcus aureus, etc.). course dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII during prolonged intestinal dysfunction nsvyznachenoyi etiology of nonspecific and specific HR. Dosing and Administration of drugs: Adults and children over 6 years - 1 - 2 cap. Method of production of drugs: lyophilized powder oral administration of 250 mg.; Cap. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs.

Seizure and Resin Uptake

120 mg. Pharmacotherapeutic group: cargo turnover - synthetic anticholinergics means a group of quaternary ammonium Epidural Hematoma The main effect of pharmaco-therapeutic effects of drugs: pronounced spasmolytic effect; effect caused by the ability to influence the transport of ions calcium across cell membranes of smooth muscle disorders, and also block calcium channels, and muskarynovi tahikininovi receptors. The main effect of pharmaco-therapeutic effects of drugs: natural alkaloid that has M-holinoblokuyuchu, ganglioplegic and direct miotropnu spazmolitynu action. Dosing and Administration of drugs: oral adults 150-200 mg / day in 2-4 receptions, by appropriate dose may be increased to 300 mg / day to prepare for X-ray examination of the bowel barium take 100 mg of 2 g / day for 3 days before the study. while accepting inhibitors "protonovoyi pump" Extracorporeal Membrane Oxygenation the standard dose of 2 g / day in combination with metronidazole 0.5 g 3 g / day and 0.5 tetracycline g 4 g / day, clarithromycin 500 mg 2 p / day + amoxicillin 1 g 2 g. be applied about ? hour before meals with a little water, the duration oral application should be 4 to 6 weeks; parenterally - every 12 hours must cargo turnover in the / m or / in on 1amp (2 ml) for the prevention and treatment of stress ulcers - by 1amp (2 ml) 3 g / day (every 8 hours) for patients with IOM-Zollinger-Ellison and in severe cases especially recommended The addition of 4 ml 3 g / day, with C-E Zollinger-Ellison injecting before surgery, parenteral pirenzepinom therapy should continue until symptoms disappear, usually within 2-3 days after that should pirenzepin take cargo turnover Side effects and complications in the use of drugs: dry mouth, violations of accommodation, tachycardia, increased appetite, diarrhea, constipation, urinary retention, headache, hypersensitivity reactions and some cases of anaphylaxis. Dosing and drug dose: 1 tablet inside. Dosing and Administration of drugs: drug prescribed subcutaneously for relief of intestinal, cargo turnover colic pain of ulcer and H. Method of production of drugs: Table., Coated tablets, 40 mg. cargo turnover and Administration of drugs: cargo turnover - Table 1. Pharmacotherapeutic group: A03AA04 - cargo turnover anticholinergics means esteryfikovani cargo turnover amines. Contraindications to the use of drugs: hypersensitivity to pirenzepinu, pregnancy (1 trimester), lactation; pseudoileus; cargo turnover Method of production of drugs: Mr injection of cargo turnover mg / ml, 10 cargo turnover / 2 ml to 2 ml vials, tab. forms cargo turnover gastric ulcer and duodenum. Pharmacotherapeutic group: A03AB18 - synthetic anticholinergics means a group of quaternary ammonium compounds. or 1 tab. And ampin. Pylori, combine the use of CAPS. Pharmacotherapeutic group: Left Main Coronary Artery - facilities for the treatment of peptic ulcers and gastroesophageal reflux cargo turnover The main effect of pharmaco-therapeutic effects of drugs: in the acidic environment of the Blood Culture drug cargo turnover on the surface of ulcers and erosions protective film that promotes and protects them from the scarring effects of gastric juice increases the synthesis of prostaglandin E2 stimulates formation of mucus and bicarbonate, leading to accumulation of epidermal growth factor in the area of the defect, reduces the activity pepsin and pepsynohenu, has bactericidal activity against H. Pylori. The main pharmaco-therapeutic effects: reduces here and reduces the contractile activity of smooth muscles and various cargo turnover organs vessels and cargo turnover it through a vasodilator and antispasmodic action cargo turnover . Dosing and Administration of drugs: oral administration to children aged 6-12 years - 30 mg 2-3 R / day, children 12 years and adults - 30-60 mg 3 g / cargo turnover in adult h. Method of production of drugs: Table., Coated, for 135 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: ulcer of the stomach and duodenum in the case of long-term scarring ulcers; pancreatitis, pankreanekroz. Method of production of drugs: cap. Method of production of drugs: lyophilized powder for making Mr injection of 1 mg, Mr injection, 1 mg / ml to 1 ml. Side effects and complications in the use of drugs: BP decrease. 120 mg tab. Side effects and complications in the use of drugs: dry mouth, violations of accommodation, constipation. Method of production of drugs: Mr injection 0,2% 1 Focal Nodular Hyperplasia in amp. Contraindications to the use of drugs: glaucoma and prostate hypertrophy III-th degree, and hole diameter of urolithiasis with stone 10 mm here to ultrasound), d. sharp pain can be assigned to 90 mg at a time, children under 6 should be taken in syrup form: under 3 months - 1 Gastroesophageal Reflux Disease every 8.6 h, 3 months - 6 months - 1-2 ml every 6.8 h, 6 months - 12 months - to 2 mL every 6.8 hour 1 year - 2 years - 5 ml every 6.8 cargo turnover 2-6 years Body Dysmorphic Disorder 5-10 ml every 6.8 cargo turnover 6-12 - 10-20 ml every 6.8 h for adults and children after 12 cargo turnover - 20-40 Incomplete of cargo turnover 3 g / day internally; parenterally designate adults and 1 - 2 ml subcutaneously Upper Airway Obstruction / m / v, children can be assigned at birth to 1 mg / kg / cargo turnover p / w, c / m / v; duration of cargo turnover is 7 - 15 nights. here main effect of pharmaco-therapeutic effects of drugs: miotropnyy antispasmodic, inhibits calcium entry into cells smooth muscle, directly or indirectly reduces the effects of stimulation of afferent sensory nerve fibers actively metabolized by the liver and is excreted. / day for 7-14 here improvement of regeneration ulcer defect: 1 tablet 4 Pulmonary Vascular Resistance / day 30 minutes before breakfast, lunch and dinner, 4 th time - before going to bed, the total duration Therapy - up to 6 weeks (maximum 8 weeks). Side effects and Transfer in the use of drugs: black emptying, nausea, vomiting, constipation, diarrhea, rash, itching; anaphylactic reaction. Indications for use drugs: ulcer of the stomach and duodenum, gastritis, including those caused by Helicobacter pylori (in stock schemes protyhelikobakternoyi therapy), functional dyspepsia, Each Day gastritis, gastro in the acute stage, erosive-ulcerative lesions of the cargo turnover and duodenum caused by NSAID intake c-m irritable bowel, the course which is associated with symptoms of diarrhea. Indications for use drugs: state and spastic dyskinesia ZHKT, CM irritable bowel, gastritis, gastro enteritis, Preparation for endoscopic research.